Scarica l'app Stockscreener
27.95
5.92%
-1.76
Dopo l'orario di chiusura:
28.15
0.20
+0.72%
Precedente Chiudi:
$29.71
Aprire:
$29.51
Volume 24 ore:
2.02M
Relative Volume:
0.48
Capitalizzazione di mercato:
$1.53B
Reddito:
$14.34M
Utile/perdita netta:
$-199.00M
Rapporto P/E:
-7.1301
EPS:
-3.92
Flusso di cassa netto:
$-183.51M
1 W Prestazione:
-7.20%
1M Prestazione:
-51.81%
6M Prestazione:
+90.01%
1 anno Prestazione:
+380.24%
Intervallo 1D:
$26.82
$30.00
Intervallo di 1 settimana:
$26.82
$31.38
Portata 52W:
$5.50
$71.50
Uniqure N V Stock (QURE) Company Profile
Nome
Uniqure N V
Settore
Industria
Telefono
1-339-970-7000
Indirizzo
PAASHEUVELWEG 25A, AMSTERDAM
Confronta QURE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QURE
Uniqure N V
|
27.95 | 1.85B | 14.34M | -199.00M | -183.51M | -3.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.03 | 110.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
702.75 | 76.23B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.76 | 61.08B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
914.59 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
203.56 | 43.00B | 447.02M | -1.18B | -906.14M | -6.1812 |
Uniqure N V Stock (QURE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-04 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-08-14 | Aggiornamento | Mizuho | Neutral → Outperform |
| 2025-04-01 | Ripresa | Chardan Capital Markets | Buy |
| 2024-12-10 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-10-10 | Ripresa | Raymond James | Outperform |
| 2024-02-29 | Downgrade | Goldman | Buy → Neutral |
| 2023-12-19 | Downgrade | Mizuho | Buy → Neutral |
| 2022-03-17 | Aggiornamento | UBS | Neutral → Buy |
| 2021-06-15 | Iniziato | BTIG Research | Buy |
| 2021-05-21 | Iniziato | UBS | Neutral |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-04-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2021-01-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-11-24 | Iniziato | H.C. Wainwright | Buy |
| 2020-11-11 | Iniziato | Berenberg | Buy |
| 2020-11-09 | Iniziato | Jefferies | Buy |
| 2020-11-04 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-08-25 | Iniziato | Raymond James | Strong Buy |
| 2020-07-31 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-06-25 | Downgrade | Mizuho | Buy → Neutral |
| 2020-06-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-06-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2019-12-03 | Iniziato | Cowen | Outperform |
| 2019-12-03 | Iniziato | Goldman | Buy |
| 2019-11-05 | Iniziato | Credit Suisse | Outperform |
| 2019-10-11 | Iniziato | Stifel | Buy |
| 2019-09-25 | Iniziato | Bernstein | Outperform |
| 2019-09-12 | Iniziato | Mizuho | Buy |
| 2019-07-30 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-07-08 | Reiterato | Cantor Fitzgerald | Overweight |
| 2019-04-12 | Iniziato | Piper Jaffray | Overweight |
| 2019-03-29 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Uniqure N V Borsa (QURE) Ultime notizie
uniQure N.V. (QURE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Summers Value Partners Established a Position in UniQure N.V. (QURE) in Q3 - Insider Monkey
Is uniQure N.V. (UQ1) stock supported by strong fundamentalsQuarterly Investment Review & Safe Entry Momentum Tips - newser.com
Can uniQure N.V. (UQ1) stock sustain revenue momentumQuarterly Earnings Summary & Detailed Earnings Play Strategies - newser.com
Will uniQure N.V. stock deliver shareholder valueWeekly Market Summary & Safe Capital Allocation Plans - newser.com
Why uniQure N.V. (UQ1) stock is trending on social media2025 Geopolitical Influence & Safe Investment Capital Preservation Plans - newser.com
Is uniQure N.V. stock a buy on dipsTrade Performance Summary & Risk Controlled Swing Alerts - newser.com
Predicting uniQure N.V. trend using moving averagesQuarterly Profit Summary & Real-Time Buy Zone Alerts - newser.com
Do Rising Losses at uniQure (QURE) Reflect Strategic Investment or Escalating Cost Pressure? - simplywall.st
Hemophilia B Research Report 2025-2035: Market Led by UniQure, Pfizer, Novo Nordisk, HEMA Biologics, and Alnylam Pharmaceuticals as Next-Generation Therapies and R&D Investment Drive Innovation - Yahoo Finance
How currency fluctuations impact uniQure N.V. stockMarket Sentiment Report & Real-Time Volume Analysis - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating uniQure N.V. (QURE) And Encourages Shareholders to Connect - ACCESS Newswire
Wall Street Has a Positive Outlook on uniQure N.V. (QURE) Despite Challenges From The FDA - MSN
What data driven models say about uniQure N.V.’s futureQuarterly Trade Report & Expert Verified Stock Movement Alerts - newser.com
Volatility clustering patterns for uniQure N.V.Weekly Stock Report & High Accuracy Swing Entry Alerts - newser.com
How to read the order book for uniQure N.V.2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Risk adjusted return profile for uniQure N.V. analyzedJuly 2025 Sector Moves & Stepwise Trade Execution Plans - newser.com
uniQure N.V. Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - FinancialContent
uniQure NV Hits Day High with 15.18% Surge Amid Market Volatility - Markets Mojo
uniQure N.V. (NASDAQ:QURE) Analysts Just Slashed Next Year's Revenue Estimates By 26% - Yahoo Finance
Can uniQure N.V. stock hit analyst price targetsJuly 2025 Selloffs & Verified Momentum Stock Ideas - newser.com
UniQure N.V. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsQURE - 富途牛牛
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
How institutional buying supports uniQure N.V. stock2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - newser.com
What catalysts could drive uniQure N.V. stock higherJuly 2025 Institutional & Scalable Portfolio Growth Methods - newser.com
Why uniQure N.V. stock is rated strong buyWeekly Gains Report & Verified Entry Point Detection - Fundação Cultural do Pará
uniQure (QURE) Surges 17.9% Ahead of 2 Health Conferences - MSN
NASDAQ: QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - NewMediaWire
FDA Unveils New Path for Approving Rare Disease Drugs for Just One Person - Bloomberg.com
Makary, Prasad outline pathway for bespoke gene therapy - statnews.com
Uniqure’s CEO dined with investors. Here’s what he said - statnews.com
Analysts Have Lowered Expectations For uniQure N.V. (NASDAQ:QURE) After Its Latest Results - Yahoo Finance
NASDAQ: QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - NewMediaWire
Bronstein, Gewirtz & Grossman, LLC Is Investigating uniQure N.V. (QURE) And Encourages Investors to Connect - ACCESS Newswire
uniQure (QURE): Wells Fargo Adjusts Price Target to $60, Maintai - GuruFocus
Uniqure N V Azioni (QURE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):